117 results
8-K
AMRN
Amarin Corp
29 Nov 12
Other Events
12:00am
Corporation plc (“Amarin”) previously guided that it would make a decision to hire prospective sales representatives as part of its continued Vascepa® … , including statements concerning the timing of Amarin’s decision to hire prospective sales representatives for Vascepa commercialization and the timing
10-K
2010 FY
EX-10.43
AMRN
Amarin Corp
16 Mar 11
Annual report
12:00am
of this Agreement. Executive acknowledges that all work performed by Executive for the Company is on a “work for hire” basis, and Executive hereby assigns … that the Company elects to hire a new Chief Executive Officer (including, without limitation, upon your recommendation), the Executive agrees to resign
8-K
EX-10.2
AMRN
Amarin Corp
23 Dec 11
Departure of Directors or Certain Officers
12:00am
for hire” basis, and I hereby do assign and transfer and, to the extent any such assignment cannot be made at present, will assign and transfer … or consultant of the Company to leave the Company for any reason or otherwise participate in or facilitate the hire, directly or through another entity, of any
8-K
EX-10.1
AMRN
Amarin Corp
23 Dec 11
Departure of Directors or Certain Officers
12:00am
by me is on a “work for hire” basis, and I hereby do assign and transfer and, to the extent any such assignment cannot be made at present, will assign … employee or consultant of the Company to leave the Company for any reason or otherwise participate in or facilitate the hire, directly or through another
8-K
EX-10.4
AMRN
Amarin Corp
23 Dec 11
Departure of Directors or Certain Officers
12:00am
acknowledge that all work performed by me is on a “work for hire” basis, and I hereby do assign and transfer and, to the extent any such assignment … the hire, directly or through another entity, of any person who is employed or engaged by the Company or who was employed or engaged by the Company
10-K
EX-10.45
jukf7lre8q2zkpqahs
16 Mar 11
Annual report
12:00am
8-K
EX-10.3
i6ua0y3qsc2nhpkg3
23 Dec 11
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.2
3wdrhdz6jbi
29 Apr 21
Amarin Reports First Quarter 2021 Financial Results and Provides Business Update
6:20am
8-K
EX-99.1
dn7ta29533k45kp75t
18 Jul 23
Amarin Implements Organizational Restructuring to Strengthen the Company While Driving Patient
4:25pm
8-K
EX-99.1
k3xz a5c9
5 Nov 19
Amarin Reports Third Quarter 2019 Financial Results and Provides Update on Operations
6:30am
F-3
EX-4.24
j53ih a8nt
20 Dec 04
Shelf registration (foreign)
12:00am
6-K
EX-99.1
f647vj5q 4up3
10 Sep 04
Current report (foreign)
12:00am
10-Q
EX-10.1
h2fzp
10 May 11
Quarterly report
12:00am
8-K
EX-99.1
ktdu44va
9 Aug 19
Amarin Announces FDA Notification of Advisory Committee Meeting Planned to be Held in November 2019 in Connection With Vascepa®REDUCE-IT™ sNDA
7:21am
10-K
EX-10.20
bte9b5sjbf
16 Mar 11
Annual report
12:00am
F-1
EX-4.104
2urhirxy0f5xfaedl
14 Dec 09
Registration statement (foreign)
12:00am